Education
About Us
Working with TipRanks
Follow Us
Financiere de Tubize (DE:FTD)
:FTD
FTD Stock Chart & Stats
Day’s Range― - ―
52-Week Range€102.60 - €154.20
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.74B
Enterprise Value€5.84B
Total Cash (Recent Filing)€1.43M
Total Debt (Recent Filing)€41.30M
Price to Earnings (P/E)63.8
Beta0.47
Next Earnings
Aug 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 30, 2025Dividend Yield0.56%
Share Statistics
EPS (TTM)-0.06
Shares Outstanding44,512,600
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio129.93
Price to Book (P/B)3.15
Price to Sales (P/S)0.00
P/FCF Ratio-3.17K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Financiere de Tubize News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.04%
Mutual Funds
― Other Institutional Investors
98.27% Public Companies and
Individual Investors
FTD FAQ
What was Financiere de Tubize’s price range in the past 12 months?
Financiere de Tubize lowest stock price was €102.60 and its highest was €154.20 in the past 12 months.
What is Financiere de Tubize’s market cap?
Financiere de Tubize’s market cap is €5.74B.
When is Financiere de Tubize’s upcoming earnings report date?
Financiere de Tubize’s upcoming earnings report date is Aug 02, 2025 which is in 46 days.
How were Financiere de Tubize’s earnings last quarter?
Financiere de Tubize released its earnings results on Mar 22, 2025. The company reported -€0.064 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.064.
Is Financiere de Tubize overvalued?
According to Wall Street analysts Financiere de Tubize’s price is currently Overvalued.
Does Financiere de Tubize pay dividends?
Financiere de Tubize pays a Annually dividend of €0.727 which represents an annual dividend yield of 0.56%. See more information on Financiere de Tubize dividends here
What is Financiere de Tubize’s EPS estimate?
Financiere de Tubize’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Financiere de Tubize have?
Financiere de Tubize has 44,512,600 shares outstanding.
What happened to Financiere de Tubize’s price movement after its last earnings report?
Financiere de Tubize reported an EPS of -€0.064 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.361%.
Which hedge fund is a major shareholder of Financiere de Tubize?
Currently, no hedge funds are holding shares in DE:FTD
Company Description
Financiere de Tubize
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Evenity, an injection for osteoporosis; and Bimzelx to treat moderate to severe plaque psoriasis. The company's products in pipeline include Staccato to treat stereotypical prolonged seizures; Bepranemab for the treatment of Alzheimer's disease; UCB0599 for Parkinson's disease; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is based in Brussels, Belgium.